Cerus Corp.
(NASDAQ : CERS)

( )
CERS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.33%104.130.6%$434.28m
ABTAbbott Laboratories
0.86%85.510.8%$411.87m
TMOThermo Fisher Scientific Inc.
1.19%279.441.0%$385.43m
ALGNAlign Technology, Inc.
0.19%177.626.3%$351.79m
ISRGIntuitive Surgical, Inc.
0.01%495.502.4%$292.16m
BDXBecton, Dickinson and Company
1.23%251.381.1%$273.83m
SYKStryker Corporation
0.74%218.601.3%$235.92m
EWEdwards Lifesciences Corporation
1.46%222.541.2%$226.01m
BSXBoston Scientific Corporation
1.38%42.731.1%$214.52m
ZBHZimmer Biomet Holdings, Inc.
1.12%138.541.7%$205.23m
BAXBaxter International Inc.
1.04%87.871.7%$196.71m
ABMDABIOMED, Inc.
-0.36%192.313.3%$158.93m
DXCMDexCom, Inc.
-0.06%163.598.3%$152.97m
WATWaters Corporation
2.10%209.863.8%$119.29m
IDXXIDEXX Laboratories, Inc.
1.50%279.533.7%$112.11m

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The company produces blood system for platelets and plasma. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.